Big Pharma Shakeup: Neurocrine Buys Soleno for Breakthrough Hunger Drug
Neurocrine’s $2.9 Billion Bet: A Strategic Move Into Rare Diseases In a…
Novartis Makes $12 Billion Move to Acquire U.S. Biotech Firm Avidity Biosciences in Cash Deal
Novartis to Acquire Avidity Biosciences in $12 Billion Cash Deal Swiss pharmaceutical…